Interview with Prof. Bardelli about Liquid Biopsies

In an IFOM interview, MErCuRIC researcher Prof. Alberto Bardelli of the Universita Degli Studi di Torino talks about why he studies colorectal cancer.

He describes personalised medicine, targeted therapies and resistance to therapy, as well as monitoring therapy in real time with blood-based assays called liquid biopsies.

You can watch the interview here.

Screen Shot 2015-10-09 at 14.04.26